» Articles » PMID: 27583639

A Decade of Progress in Tissue Engineering

Overview
Journal Nat Protoc
Specialties Biology
Pathology
Science
Date 2016 Sep 2
PMID 27583639
Citations 223
Authors
Affiliations
Soon will be listed here.
Abstract

Tremendous progress has been achieved in the field of tissue engineering in the past decade. Several major challenges laid down 10 years ago, have been studied, including renewable cell sources, biomaterials with tunable properties, mitigation of host responses, and vascularization. Here we review advancements in these areas and envision directions of further development.

Citing Articles

Critical roles of miR-21 in promotions angiogenesis: friend or foe?.

Saadh M, Jasim N, Ahmed M, Ballal S, Kumar A, Atteri S Clin Exp Med. 2025; 25(1):66.

PMID: 39998742 PMC: 11861128. DOI: 10.1007/s10238-025-01600-7.


Development of a Novel Hybprinter-SAM for Functionally Graded Tissue Engineering Constructs with Patterned and Localized Biochemical Signals.

Yang Y, Li J, Kim C, Alizadeh H, Garg S, Alizadeh H Res Sq. 2025; .

PMID: 39975888 PMC: 11838729. DOI: 10.21203/rs.3.rs-5898561/v1.


Assessing the landscape of clinical and observational trials involving bioprinting: a scoping review.

Briones Y, Pascua B, Tiangco N, Crisostomo I, Casiguran S, Remenyi R 3D Print Med. 2025; 11(1):5.

PMID: 39961914 PMC: 11834296. DOI: 10.1186/s41205-025-00253-2.


Mechanical and functional characterisation of a 3D porous biomimetic extracellular matrix to study insulin secretion from pancreatic β-cell lines.

Pliner L, Laneret N, Roudaut M, Mogrovejo-Valdivia A, Vandenhaute E, Maubon N In Vitro Model. 2025; 3(4-6):205-218.

PMID: 39872697 PMC: 11756461. DOI: 10.1007/s44164-024-00078-z.


Engineered biomaterials in stem cell-based regenerative medicine.

Zhu F, Nie G, Liu C Life Med. 2025; 2(4):lnad027.

PMID: 39872549 PMC: 11749850. DOI: 10.1093/lifemedi/lnad027.


References
1.
Du Y, Ghodousi M, Lo E, Vidula M, Emiroglu O, Khademhosseini A . Surface-directed assembly of cell-laden microgels. Biotechnol Bioeng. 2009; 105(3):655-62. PMC: 2833321. DOI: 10.1002/bit.22552. View

2.
Wilmer M, Ng C, Lanz H, Vulto P, Suter-Dick L, Masereeuw R . Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening. Trends Biotechnol. 2015; 34(2):156-170. DOI: 10.1016/j.tibtech.2015.11.001. View

3.
Huebsch N, Arany P, Mao A, Shvartsman D, Ali O, Bencherif S . Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater. 2010; 9(6):518-26. PMC: 2919753. DOI: 10.1038/nmat2732. View

4.
Menze M, Chakraborty N, Clavenna M, Banerjee M, Liu X, Toner M . Metabolic preconditioning of cells with AICAR-riboside: improved cryopreservation and cell-type specific impacts on energetics and proliferation. Cryobiology. 2010; 61(1):79-88. PMC: 2920351. DOI: 10.1016/j.cryobiol.2010.05.004. View

5.
Zhang W, Zhang Y, Bakht S, Aleman J, Shin S, Yue K . Elastomeric free-form blood vessels for interconnecting organs on chip systems. Lab Chip. 2016; 16(9):1579-86. PMC: 4846563. DOI: 10.1039/c6lc00001k. View